Chronic kidney disease: Mortality and serum sodium in CKD-yet another U-shaped curve

Nature Reviews Nephrology

Volumn 8, Issue 5, 2012, Pages 261-263

  Jovanovich, Anna ^a   Berl, Tomas ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE; POTASSIUM; SODIUM; TOLVAPTAN;

ARTICLE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HEALTH HAZARD; HEART FAILURE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPERNATREMIA; HYPOKALEMIA; HYPONATREMIA; MORTALITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS;

HUMANS; HYPERNATREMIA; HYPONATREMIA; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MULTIVARIATE ANALYSIS;

EID: 84860315485     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2012.65     Document Type: Article

References (10)

1. Waikar, S. S., Mount, D. B. & Curhan, G. C. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am. J. Med. 122, 857-865 (2009).
2. Funk, G. C. et al. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 36, 304-311 (2010).
3. Stelfox, H. T., Ahmed, S. B., Zygun, D., Khandwala, F. & Laupland, K. Characterization of intensive care unit acquired hyponatremia and hypernatremia following cardiac surgery. Can. J. Anaesth. 57, 650-658 (2010).
4. Kovesdy, C. P. et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 125, 677-684 (2012).
5. Waikar, S. S., Curhan, G. C. & Brunelli, S. M. Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am. J. Med. 124, 77-84 (2011).
6. Hayes, J. et al. Association of hypo-and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron Clin. Pract. 120, 8-16 (2011).
7. Lukowsky, L. R. et al. Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol. Dial. Transplant http://dx.doi.org/10.1093/ndt/gfr747.
8. Rozen-Zvi, B. et al. Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis. Am. J. Kidney Dis. 56, 325-337 (2010).
9. 2-receptor antagonist, for hyponatremia. N. Engl. J. Med. 355, 2099-2112 (2006). (Pubitemid 44749318)
10. Cyr, P. L. et al. Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure. Am. J. Health Syst. Pharm. 68, 328-333 (2011).